NO20004345L
Pharmaceutical composition for use in treatment of diabetes
Abstract
Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
Term
No projected expiry on record.
- Priority
- Published
- Filed
- Today
161 members in 27 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 15350095 | Japan | A |
Members161
| Document | Office | Kind | |
|---|---|---|---|
| NO962606D0 | Norway | D0 | |
| HU9601698D0 | Hungary | D0 | |
| CA2179584A1 | Canada | A1 | |
| CA2531834A1 | Canada | A1 | |
| CA2533845A1 | Canada | A1 | |
| NO20004345LThis record | Norway | L | |
| NO20021172L | Norway | L | |
| NO962606L | Norway | L | |
| EP0749751A2 | European Patent Office (EPO) | A2 | |
| SK79496A3 | Slovakia | A3 | |
| AU5603496A | Australia | A | |
| CZ181196A3 | Czechia | A3 | |
| KR970000233A | Republic of Korea | A | |
| MX9602399A | Mexico | A | |
| JPH0967271A | Japan | A | |
| CN1145783A | China | A | |
| EP0749751A3 | European Patent Office (EPO) | A3 | |
| HU9601698A2 | Hungary | A2 | |
| HUP9601698A2 | Hungary | A2 | |
| ZA965190B | South Africa | B | |
| JPH10167986A | Japan | A | |
| EP0861666A2 | European Patent Office (EPO) | A2 | |
| EP0861666A3 | European Patent Office (EPO) | A3 | |
| HK1010484A | Hong Kong, China | A | |
| HK1010484A1 | Hong Kong, China | A1 | |
| AR005641A1 | Argentina | A1 | |
| US5952356A | United States of America | A | |
| US5965584A | United States of America | A | |
| US6080765A | United States of America | A | |
| US6103742A | United States of America | A | |
| AU723097B2 | Australia | B2 | |
| NO20004345D0 | Norway | D0 | |
| US6121294A | United States of America | A | |
| US6121295A | United States of America | A | |
| HU9601698A3 | Hungary | A3 | |
| HUP9601698A3 | Hungary | A3 | |
| US6133293A | United States of America | A | |
| US6133295A | United States of America | A | |
| US6150383A | United States of America | A | |
| US6150384A | United States of America | A | |
| US6156773A | United States of America | A | |
| US6166042A | United States of America | A | |
| US6166043A | United States of America | A | |
| US6169099B1 | United States of America | B1 | |
| US6169100B1 | United States of America | B1 | |
| US6172089B1 | United States of America | B1 | |
| US6172090B1 | United States of America | B1 | |
| US6174904B1 | United States of America | B1 | |
| JP3148973B2 | Japan | B2 | |
| US6211205B1 | United States of America | B1 | |
| US6211206B1 | United States of America | B1 | |
| US6211207B1 | United States of America | B1 | |
| US6214848B1 | United States of America | B1 | |
| US6218409B1 | United States of America | B1 | |
| US6225326B1 | United States of America | B1 | |
| US6232330B1 | United States of America | B1 | |
| US6239153B1 | United States of America | B1 | |
| TW438587B | Taiwan Province of China | B | |
| US6251924B1 | United States of America | B1 | |
| US6271243B1 | United States of America | B1 | |
| US6274605B1 | United States of America | B1 | |
| US6277869B1 | United States of America | B1 | |
| US6288090B1 | United States of America | B1 | |
| US6303640B1 | United States of America | B1 | |
| US6323225B1 | United States of America | B1 | |
| US6329404B1 | United States of America | B1 | |
| US2002002186A1 | United States of America | A1 | |
| EP1174135A2 | European Patent Office (EPO) | A2 | |
| NO20021172D0 | Norway | D0 | |
| US2002042434A1 | United States of America | A1 | |
| US6384062B1 | United States of America | B1 | |
| EP1174135A3 | European Patent Office (EPO) | A3 | |
| HK1041203A | Hong Kong, China | A | |
| HK1041203A1 | Hong Kong, China | A1 | |
| NO313226B1 | Norway | B1 | |
| US2002123512A1 | United States of America | A1 | |
| US2002128289A1 | United States of America | A1 | |
| NO314065B1 | Norway | B1 | |
| RU2198682C2 | Russian Federation | C2 | |
| CZ291624B6 | Czechia | B6 | |
| CZ292093B6 | Czechia | B6 | |
| US6599923B2 | United States of America | B2 | |
| US2003216443A1 | United States of America | A1 | |
| EP0861666B1 | European Patent Office (EPO) | B1 | |
| AT256463T | Austria | T | |
| ATE256463T1 | Austria | T1 | |
| DE69631157D1 | Germany | D1 | |
| RU2223760C2 | Russian Federation | C2 | |
| DK0861666T3 | Denmark | T3 | |
| PT861666E | Portugal | E | |
| ES2212208T3 | Spain | T3 | |
| DE69631157T2 | Germany | T2 | |
| CN1530105A | China | A | |
| CN1530106A | China | A | |
| NO317341B1 | Norway | B1 | |
| CY2424B1 | Cyprus | B1 | |
| US2004266830A1 | United States of America | A1 | |
| US2005054685A1 | United States of America | A1 | |
| RU2003130978A | Russian Federation | A | |
| US6911459B2 | United States of America | B2 |
Showing 100 of 161
4 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Expiry of an spcSPCX | SPCX | |
| Patent expiredExpiredMK1K | MK1K | |
| Granted supplementary protection certificateGrantedSPCG | SPCG | |
| Filing of supplementary protection certificateSPCF | SPCF |
Numbers
- Application
- 4345
Titles2
- English
- Pharmaceutical composition
- Norwegian
- Farmasøytisk sammensetning
Classification
- CPC, 27
- A61K9/2018
- A61K31/4427
- A61K9/2054
- A61K9/4858
- A61K31/4245
- A61K31/425
- A61K31/44
- A61K31/4439
- A61K31/445
- A61K31/52
- A61K31/64
- A61K31/70
- A61K45/06
- A61K31/135
- A61K31/19
- A61K31/415
- A61K31/42
- A61K31/50
- A61K31/535
- A61P3/00
- A61P3/10
- A61P31/10
- A61P3/08
- A61P43/00
- A61P5/00
- A61P5/48
- A61P5/50
- IPC, 28
- A61K45 06
- A61K9 20
- A61K9 48
- A61K31 00
- A61K31 133
- A61K31 155
- A61K31 18
- A61K31 33
- A61K31 41
- A61K31 421
- A61K31 4245
- A61K31 425
- A61K31 426
- A61K31 44
- A61K31 4439
- A61K31 445
- A61K31 52
- A61K31 64
- A61K31 70
- A61K31 702
- A61P3 08
- A61P3 10
- A61P5 50
- A61P43 00
- C07D233 54
- C07D263 44
- C07D277 20
- C07D277 34